The GCC Microarray Market region focuses on Saudi Arabia, UAE, Qatar, Kuwait, and Bahrain. Saudi Arabia leads the market due to extensive investment in biotechnology and healthcare infrastructure, while UAE and Qatar are expanding research laboratories and precision medicine programs. Regional adoption is also supported by national genomic initiatives and funding for disease-specific...